Dietary Supplementation with γ-Aminobutyric Acid Improves Growth, Digestive Enzyme Activity, Non-Specific Immunity and Disease Resistance against Streptococcus iniae in Juvenile Olive Flounder, Paralichthys olivaceus .
Nathaniel W FarrisAli HamidoghliJinho BaeSeonghun WonWonsuk ChoiJanka BiróSeunghyung LeeSungchul C BaiPublished in: Animals : an open access journal from MDPI (2022)
Recent research is increasingly shedding light on the important role that microbial metabolites such as γ-aminobutyric acid (GABA) play in the context of nutrition, cognition, immune function, and the modulation of the gut microbiome. Yet, very few trials were conducted to assess the effects of its supplementation on biomarkers of fish health. Therefore, an eight-week feeding trial was devised to evaluate GABA supplementation in juvenile olive flounder, ( Paralichthys olivaceus ). A total of 630 fish with an average weight of 4.90 ± 0.10 g (±SD) were randomly assigned to one of seven triplicate groups and fed a non-GABA supplemented diet (CON, with 92 mg/kg GABA content), a positive control with 4 g/kg oxytetracycline (OTC), and five other diets supplemented with 50, 100, 150, 200 and 250 mg/kg GABA (corresponding to a total GABA content of 154, 229, 282, 327 and 352 mg/kg, respectively). Growth, blood chemistry, nonspecific immunity, digestive enzyme activity and disease resistance were assessed. The results showed that 100 and 150 mg/kg GABA supplementation consistently yielded significant improvements ( p < 0.05) in growth, intestinal amylase, serum lysozyme, and survival against infection with Streptococcus iniae . Based on polynomial analysis, the optimal supplementation level was determined to be 237 mg/kg. These results support GABA as an important functional feed additive in juvenile olive flounder.
Keyphrases
- physical activity
- weight loss
- public health
- body mass index
- randomized controlled trial
- ms ms
- microbial community
- mental health
- biofilm formation
- escherichia coli
- staphylococcus aureus
- multiple sclerosis
- risk assessment
- mild cognitive impairment
- social media
- health information
- wastewater treatment
- cystic fibrosis
- weight gain
- health promotion
- open label
- double blind
- antibiotic resistance genes